Daytrana (methylphenidate) transdermal system patch, Delivers 10 mg over 9 hours (1.1 mg/hr), 1 p...

FDA Recall #D-1375-2012 — Class II — July 5, 2011

Recall #D-1375-2012 Date: July 5, 2011 Classification: Class II Status: Terminated

Product Description

Daytrana (methylphenidate) transdermal system patch, Delivers 10 mg over 9 hours (1.1 mg/hr), 1 patch per pouch (NDC 54092-552-01), packaged in 30-count patches per box (NDC 54092-552-30), Rx only, Manufactured for Shire US Inc., Wayne, PA 19087; by Noven Pharmaceuticals, Inc., Miami, FL 33186.

Reason for Recall

Miscalibrated and/or Defective Delivery System: Out of Specification results for mechanical peel force and/or the z-statistic value which relates to the patient's ability to remove the release liner from the patch adhesive prior to administration.

Recalling Firm

Noven Pharmaceuticals, Inc. — Miami, FL

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

335,190 patches

Distribution

Nationwide and Puerto Rico.

Code Information

Lot #: 41843, Exp 11/11

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated